Literature DB >> 2944864

Pharmacokinetics of single dose intravenous ciprofloxacin in patients undergoing gastrointestinal surgery.

S H Silverman, M Johnson, D W Burdon, M R Keighley.   

Abstract

The pharmacokinetics of single dose intravenous ciprofloxacin in patients undergoing gastrointestinal surgery (100 mg, n = 8; 200 mg n = 18) have been studied. Following 100 mg therapeutic serum levels were maintained for approximately 40 min only and tissue concentrations were frequently less than 0.15 mg/kg. 200 mg maintained therapeutic serum levels for at least 150 min and produced mean concentrations in fat, muscle, peritoneum and gut wall of 1.04, 1.94, 1.59, and 3.39 mg/kg respectively. 200 mg iv ciprofloxacin would appear to provide adequate serum and tissue concentrations for at least 150 min.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2944864     DOI: 10.1093/jac/18.1.107

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  4 in total

Review 1.  Clinical pharmacokinetics of ciprofloxacin.

Authors:  K Vance-Bryan; D R Guay; J C Rotschafer
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

2.  Ciprofloxacin concentrations and impact of the colon microflora in patients undergoing colorectal surgery.

Authors:  B Brismar; C Edlund; A S Malmborg; C E Nord
Journal:  Antimicrob Agents Chemother       Date:  1990-03       Impact factor: 5.191

Review 3.  Worldwide clinical data on efficacy and safety of ciprofloxacin.

Authors:  P Schacht; G Arcieri; J Branolte; H Bruck; V Chyský; E Griffith; G Gruenwaldt; R Hullmann; C A Konopka; B O'Brien
Journal:  Infection       Date:  1988       Impact factor: 3.553

4.  A genomic portrait of the emergence, evolution, and global spread of a methicillin-resistant Staphylococcus aureus pandemic.

Authors:  Matthew T G Holden; Li-Yang Hsu; Kevin Kurt; Lucy A Weinert; Alison E Mather; Simon R Harris; Birgit Strommenger; Franziska Layer; Wolfgang Witte; Herminia de Lencastre; Robert Skov; Henrik Westh; Helena Zemlicková; Geoffrey Coombs; Angela M Kearns; Robert L R Hill; Jonathan Edgeworth; Ian Gould; Vanya Gant; Jonathan Cooke; Giles F Edwards; Paul R McAdam; Kate E Templeton; Angela McCann; Zhemin Zhou; Santiago Castillo-Ramírez; Edward J Feil; Lyndsey O Hudson; Mark C Enright; Francois Balloux; David M Aanensen; Brian G Spratt; J Ross Fitzgerald; Julian Parkhill; Mark Achtman; Stephen D Bentley; Ulrich Nübel
Journal:  Genome Res       Date:  2013-01-08       Impact factor: 9.043

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.